• DOI:10.1007/s00277-003-0608-2
Corpus ID: 27279071

Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase

@article{Woessmann2003IncidenceOT,
  title={Incidence of tumor lysis syndrome in children with advanced stage Burkitt's lymphoma/leukemia before and after introduction of prophylactic use of urate oxidase},
  author={W. Woessmann and M. Schrappe and U. Meyer and Martin Zimmermann and A. Reiter},
  journal={Annals of Hematology},
  year={2003},
  volume={82},
  pages={160-165}
}

W. Woessmann, M. Schrappe, +2 authors A. Reiter

Published 2003

Medicine

Annals of Hematology

To evaluate the clinical benefit of the prophylactic use of urate oxidase in children with non-Hodgkin's lymphoma (NHL), we analyzed the incidence and complications of tumor lysis syndrome (TLS) in children with B-cell acute lymphoblastic leukemia (B-ALL) or stage III/IV Burkitt's lymphoma and a lactate dehydrogenase (LDH) level ≥500 U/l before and after the introduction of a protocol amendment to use urate oxidase for the prophylaxes of TLS. Data from 1791 children with NHL enrolled in the two… CONTINUE READING

View on Springer

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed